dsm-firmenich announced October 22, 2026, that the standalone companies emerging from the sale of its Animal Nutrition & Health business to private equity firm CVC Capital Partners will be called Noviwest and Panavora. Both will operate independently but collaborate in selected areas where their capabilities complement each other, with launches expected in early 2027.
“The completion is on track for end of this year,” Silvia Sonneveld, designated CEO of Noviwest and head of the vitamins unit at dsm-firmenich ANH, told Expana at EuroTier in Hanover, Germany, on November 10, 2026.
Until the sale is completed, ANH will remain part of dsm-firmenich. After completion of the transaction, CVC will acquire 80% of both companies, while dsm-firmenich retains a 20% equity interest in each. Noviwest will focus on vitamins, carotenoids and aroma ingredients, while Panavora will oversee the premix distribution network, specialty feed additives, and additional services and solutions including digital products.
Noviwest will be headquartered in Switzerland and have about 3,500 employees, most of them in Europe, with many customer-facing staff across all major global markets.
“Serving customers reliably and with highest quality standard remains our top priority throughout the entire process,” Sonneveld said. “We’re now in the last mile of the separation, and now we can focus more externally on customers than before to ensure that they know where to find us and find what they are used to.”
“Noviwest may be smaller in size but we will be entirely focused on vitamins, carotenoids, and aroma ingredients, and will become a privately held company,” she said. “As Noviwest we will be nimble, more focused, and a pure player standalone company, recognized as a producer, which is an important benefit for customers in the market.”
Sonneveld expressed confidence about the company’s position and the private equity backing. “I’m very positive about our new ownership structure. We are increasingly able to focus on value creation.” She said CVC “brings a huge network and capabilities.” Panavora and dsm-firmenich will be “some of our biggest customers, and that’s a reassuring thing to have for the long term of the business.” Panavora, she added, “offers a strategic supplier relationship as they are a route to serve Noviwest customers with a more local go to market network than Noviwest in some areas.”
The company’s branding deliberately signals its geographic positioning. “The West in Noviwest also stands for western produced vitamins, and customers are increasingly paying attention to where their products are coming from,” Sonneveld said.
She emphasized growing government focus on supply chain security. “There is an increased awareness of governments about food and feed security with initiatives already underway in the European Union, in the US and in other countries. Vitamins are recognized as an essential building block in the current political debate on critical ingredients to safeguard undisrupted feed and food supply”
However, she warned that western producers face competitive disadvantages in the current market environment. “There also has to be a focus on creating a fairer level playing field for domestic production. Higher European energy prices are already a major cost challenge, while regulatory and certification requirements can be more burdensome for local producers than for imported products. All of this creates an uneven playing field,” Sonneveld said.
On Vitamin A and E prices, which have been under pressure in recent months, Sonneveld said: “This is a symptom of underlying oversupply in the market right now. It’ll likely lead to some consolidation in the future, but historically we haven’t seen that yet, so it’s a bit of an unknown. But with the increasing government awareness on food security and their focus on helping western producers, we may eventually see change.”
Written by Simon Duke